SAN DIEGO (AP) — SAN DIEGO (AP) — Halozyme Therapeutics Inc. (HALO) on Tuesday reported first-quarter net income of $76.8 million.

On a per-share basis, the San Diego-based company said it had profit of 60 cents. Earnings, adjusted for one-time gains and costs, came to 79 cents per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 69 cents per share.

The biopharmaceutical company posted revenue of $195.9 million in the period, which did not meet Street forecasts. Five analysts surveyed by Zacks expected $201.7 million.

Halozyme Therapeutics expects full-year earnings in the range of $3.55 to $3.90 per share, with revenue in the range of $915 million to $985 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HALO at https://www.zacks.com/ap/HALO

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News